Philippe Gadal

Philippe Gadal

Keine laufenden Positionen mehr

66 Jahre
Health Technology
Consumer Services

Ursprung des Netzwerks ersten Grades von Philippe Gadal

EinheitArt der EinheitIndustrie
Subsidiary Medical Specialties 21
3
Subsidiary Medical Specialties 3

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Philippe Gadal

UnternehmenSektorVerknüpfte PersonenHauptposition
GILEAD SCIENCES, INC. Biotechnology

J. William Freytag

Corporate Officer/Principal

Miscellaneous Commercial Services

Paul W. D. Chapman

Corporate Officer/Principal

Washington University in St. Louis College/University

Chandra Krishnan

Masters Business Admin

Biotechnology

J. William Freytag

Corporate Officer/Principal

Pharmaceuticals: Major

J. William Freytag

Director/Board Member

GLOBEIMMUNE, INC. Pharmaceuticals: Other

J. William Freytag

Chairman

Biotechnology

Jerry Christopher Benjamin

Bruno Chalom Sayada

Director/Board Member

Chief Executive Officer

Electronic Equipment/Instruments

J. William Freytag

Director/Board Member

MEMPHASYS Biotechnology

Prakash Patel

Chief Executive Officer

Miscellaneous Commercial Services

Kevin D. Clark

Gerald E. Gallwas

John B. Harley

Chief Executive Officer

Director/Board Member

Director/Board Member

College/University

Laurent Le Portz

Masters Business Admin

Pharmaceuticals: Major

J. William Freytag

Corporate Officer/Principal

University of Pennsylvania College/University

John B. Harley

Patrice R. Debrégeas

Doctorate Degree

Masters Business Admin

University of Oxford College/University

Hayden Jeffreys

Graduate Degree

Investment Managers

Laurent Le Portz

Private Equity Investor

Pharmaceuticals: Major

Patrice R. Debrégeas

Founder

Pharmaceuticals: Major

J. William Freytag

Chairman

Investment Managers

Laurent Le Portz

Investment Committee Member

Clemson University College/University

Chandra Krishnan

Doctorate Degree

Florida Atlantic University College/University

Ernesina Scala

Graduate Degree

Purdue University College/University

J. William Freytag

Undergraduate Degree

University of Kansas College/University

J. William Freytag

Doctorate Degree

Packaged Software

Bruno Chalom Sayada

Chief Executive Officer

Medical Specialties

Kevin D. Clark

Chief Operating Officer

Electronic Equipment/Instruments

Hayden Jeffreys

Director/Board Member

Medical/Nursing Services

Paul W. D. Chapman

Corporate Officer/Principal

Apparel/Footwear

Laurent Le Portz

Director/Board Member

Pharmaceuticals: Major

Bruno Chalom Sayada

Chief Executive Officer

ARCA BIOPHARMA, INC. Pharmaceuticals: Major

J. William Freytag

Director/Board Member

Pharmaceuticals: Major

Laurent Le Portz

Corporate Officer/Principal

Medical Specialties

Sanjiv Suri

Hayden Jeffreys

Corporate Officer/Principal

Corporate Officer/Principal

Debregeas Et Associes Pharma

Patrice R. Debrégeas

Founder

Roche Austria GmbH

Paul W. D. Chapman

Corporate Officer/Principal

Other Consumer Services

Laurent Le Portz

Chief Executive Officer

Aerospace & Defense

Laurent Le Portz

Chairman

Miscellaneous Commercial Services

Hayden Jeffreys

Chief Operating Officer

Miscellaneous Commercial Services

Prakash Patel

Corporate Officer/Principal

Medical Specialties

Hayden Jeffreys

Director/Board Member

YOURGENE HEALTH Medical Specialties

Hayden Jeffreys

Chief Operating Officer

Information Technology Services

Paul W. D. Chapman

Director/Board Member

Medical/Nursing Services

Paul W. D. Chapman

Chief Executive Officer

Statistik

International

Vereinigte Staaten 27
Frankreich 9
Vereinigtes Königreich 6
Kanada 4
Schweiz 3

Sektoral

Health Technology 23
Consumer Services 10
Commercial Services 8
Electronic Technology 4
Finance 3

Operativ

Director/Board Member 51
Corporate Officer/Principal 28
Chief Executive Officer 21
President 14
Chief Operating Officer 12
  1. Börse
  2. Insiders
  3. Philippe Gadal
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT